Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
Amirmohammad KhalajiNastaran BabajaniZahra AmirsardariBehrad SaeedianSoheil PeimanNathan A BergerAmir Hossein BehnoushPublished in: Inflammatory bowel diseases (2023)
Our results demonstrate that IBD patients with active disease have higher levels of ghrelin, which needs to be confirmed in future studies. Also, the obestatin/ghrelin ratio might be a promising biomarker for the assessment of disease activity.